Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3421651
Max Phase: Preclinical
Molecular Formula: C8H5BrN2S
Molecular Weight: 241.11
Molecule Type: Small molecule
Associated Items:
ID: ALA3421651
Max Phase: Preclinical
Molecular Formula: C8H5BrN2S
Molecular Weight: 241.11
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Brc1ccc(-c2cncnc2)s1
Standard InChI: InChI=1S/C8H5BrN2S/c9-8-2-1-7(12-8)6-3-10-5-11-4-6/h1-5H
Standard InChI Key: MVPVHUNJWQWPFR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 241.11 | Molecular Weight (Monoisotopic): 239.9357 | AlogP: 2.97 | #Rotatable Bonds: 1 |
Polar Surface Area: 25.78 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 0.94 | CX LogP: 2.41 | CX LogD: 2.41 |
Aromatic Rings: 2 | Heavy Atoms: 12 | QED Weighted: 0.77 | Np Likeness Score: -1.78 |
1. Verbitskiy EV, Cheprakova EM, Slepukhin PA, Kravchenko MA, Skornyakov SN, Rusinov GL, Chupakhin ON, Charushin VN.. (2015) Synthesis, and structure-activity relationship for C(4) and/or C(5) thienyl substituted pyrimidines, as a new family of antimycobacterial compounds., 97 [PMID:25982331] [10.1016/j.ejmech.2015.05.007] |
Source(1):